Clinical trial
Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy
NCT02601170 is registered in ClinicalTrials.gov with Tri-Service General Hospital (TSGH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy
- Lead sponsor
- Tri-Service General Hospital (TSGH)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- July 31, 2016
- Enrollment
- 22 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hemophilia, hemophilic arthropathy